Eli Lilly and Company (NYSE:LLY) Given New $928.00 Price Target at Guggenheim
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price target dropped by Guggenheim from $973.00 to $928.00 in a report released on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Guggenheim’s price target indicates a potential upside of 22.66% from the stock’s current price. LLY has been the […]
